How fee-for-service stymies promising, cost-saving dementia care programs
Advocates want CMS to test out comprehensive care—and value-based payment—for Alzheimer's and dementia.
Stay updated with breaking news from Dementia Care Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Advocates want CMS to test out comprehensive care—and value-based payment—for Alzheimer's and dementia.
Also, Continental Resources gave $25 million to Oklahoma State University to establish an energy institute named for its founder and chairman, and the natural-gas company Tellurian pledged $25 million to the National Forest Foundation.
New Alzheimer's drug not for most dementia patients, docs say Erika Edwards © Provided by NBC News Dr. David Reuben's phone started ringing nonstop Monday, after the Food and Drug Administration approved the first new drug for Alzheimer's disease in nearly two decades. Reuben, director of the UCLA Alzheimer's and Dementia Care Program, said patients and, more often, patient's families, were clamoring for the drug. They ask, "How can we get Mom on this drug?" or "How can I get this drug?" he said. The approval of the drug, called aducanumab, has thrown doctors into a precari...